M

MITech Co Ltd
KOSDAQ:179290

Watchlist Manager
MITech Co Ltd
KOSDAQ:179290
Watchlist
Price: 6 770 KRW 2.58%
Market Cap: 219.1B KRW

Operating Margin
MITech Co Ltd

31.4%
Current
32%
Average
3.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
31.4%
=
Operating Profit
19B
/
Revenue
60.6B

Operating Margin Across Competitors

No Stocks Found

MITech Co Ltd
Glance View

Market Cap
219.1B KRW
Industry
Health Care

M.I.Tech Co., Ltd. develops and manufactures non-vascular stent system. The company is headquartered in Pyeongtaek, Gyeonggi-Do and currently employs 157 full-time employees. The company went IPO on 2018-11-29. is a Korea-based company mainly engaged in the manufacturing and sale of stents. Stents include biliary, esophagus, pyloric, large intestine, duodenal stents, and stents for sample and study, among others. The Company’s stents are sold under the brand names of CHOOSTENT and HANAROSTENT. In addition, the Company is engaged in the manufacture and sale of low frequency therapies, crushers and blood glucose meters. The firm distributes its products within the domestic market and to overseas markets.

Intrinsic Value
14 016.31 KRW
Undervaluation 52%
Intrinsic Value
Price
M
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
31.4%
=
Operating Profit
19B
/
Revenue
60.6B
What is the Operating Margin of MITech Co Ltd?

Based on MITech Co Ltd's most recent financial statements, the company has Operating Margin of 31.4%.

Back to Top